Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
September 22, 2021     Contact    
Featured This Week
 
Cidara Therapeutics: Two Phase 3 Programs Underway
 

 


Cidara (NASDAQ: CDTX) is developing long-acting therapeutics designed to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® antiviral platform.

Cidara is headquartered in San Diego, California and is built around the core values of collaboration, integrity, accountability, urgency and courage which foster a unique and award-winning atmosphere. In 2020, Cidara was named a San Diego Metro Area top workplace for the fourth consecutive year by the San Diego Union-Tribune.

 
 >
Latest News
 
Aptorum Group (NASDAQ: APM) has Received IND Clearance from the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma
 >
Aptorum Group (NASDAQ: APM) Reports Financial Results and Business Update for the Six Months Ended June 30, 2021
 >
Esports Entertainment Group (NASDAQ: GMBL) Opens New Jersey Office; Expands Hiring Ahead of Vie Launch in US
 
 
Esports Entertainment Group's (NASDAQ: GMBL) ggCircuit Partners with Square on Retail Integration
 
 
Pro Football Retired Players Association Announces Partnership with Esports Entertainment Group (NASDAQ: GMBL) for Its Gridiron Gaming Initiative
 
 
BTCS (NASDAQ: BTCS) Commences Trading on Nasdaq
 
 
BTCS's (NASDAQ: BTCS) Expanding Blockchain Infrastructure Operations Include Avalanche Node
 
 
iSpecimen (NASDAQ: ISPC) Announces Inclusion in Russell Microcap® Index
 
 
SPI Energy’s (NASDAQ: SPI) Phoenix Motorcars Showcases Third Generation All-Electric Box Truck at the Harbor Trucking Association DrayTECH Show
 
 
SPI Energy's (NASDAQ: SPI) EdisonFuture Introduces Next Generation All-Electric Solar Delivery Van
 
 
SPI Energy's (NASDAQ: SPI) SolarJuice Receives Volume Order
 
 
BioVie (NASDAQ: BIVI) to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Virtual Summit
 
 
Can-Fite (NYSE American: CANF) to Participate in Three Upcoming Pharma Partnering Conferences
 
 
Nemaura Medical (NASDAQ: NMRD) Announce Professor Osama Hamdy Joins their Advisory Board
 
 
Head Team Physician for the NFL Jacksonville Jaguars Dr. Kevin Kaplan Joins Draganfly (NASDAQ: DPRO) Board of Advisors
 
 
DraganflY (NASDAQ: DPRO) Announces Exercise of Over-Allotment Option
 
 
Hut 8 Mining (NASDAQ: HUT) Closes US$173 Million Common Share Public Offering
 
 
DeFi Technologies' (OTC: DEFTF) Through its Subsidiary Valour, Announces Launch of Solana Exchange Traded Product on Nordic Exchange
 
 
DeFi Technologies (OTC: DEFTF) Through its Subsidiary Valour, Launches Solana Exchange Traded Product on Nordic Exchange
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/86837464152
One tap mobile :
US: +13017158592,,86837464152#,,,,*421315# or +13126266799,,86837464152#,,,,*421315#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 868 3746 4152
Passcode: 421315
International numbers available:
zoom.us/u/kcyZwoqbze


 
 
 
 
 
 

Join Zoom Meeting: zoom.us/j/84085078720
One tap mobile :
US: +16465588656,,84085078720#,,,,*298001# or +13017158592,,84085078720#,,,,*298001#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 840 8507 8720
Passcode: 298001
International numbers available:
zoom.us/u/kdw8m6krvP


 
 
 

Join Zoom Meeting: zoom.us/j/84231216947
One tap mobile :
US: +13126266799,,84231216947#,,,,*080081# or +16465588656,,84231216947#,,,,*080081#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 842 3121 6947
Passcode: 080081
International numbers available:
zoom.us/u/kgDiPv1zt


 
 
 

Join Zoom Meeting: zoom.us/j/87360031631
One tap mobile :
US: +13126266799,,87360031631#,,,,*517777# or +16465588656,,87360031631#,,,,*517777#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 873 6003 1631
Passcode: 517777
International numbers available:
zoom.us/u/kbwL7HPQL0


 
 
 

Join Zoom Meeting: zoom.us/j/86376165147
One tap mobile :
US: +13017158592,,86376165147#,,,,*398328# or +13126266799,,86376165147#,,,,*398328#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 863 7616 5147
Passcode: 398328
International numbers available:
zoom.us/u/keGxK1gF6N


 
 
 
 
 
 
 
Quote of the Week
 
"Get to know management, look for intelligence, a high level of integrity, strong communication skills, and make sure they understand their products and business well."
- Charles Diker, Diker Management
 
 
 
Lesson of the Week
 
Buying is only half the equation. You also need to know when to sell.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 3 High-Growth Small-Cap Stocks
 
This week’s episode of the RedChip Money Report features interviews with executives from Elys Gaming Group (NASDAQ: ELYS), Milestone Scientific (NYSE AMERICAN: MLSS), and Bragg Gaming Group (NASDAQ: BRAG). Learn more at www.redchip.com.
 
Watch Now
 
 
 
 
Draganfly: Professional Drone Service Provider Positioned for Continued Rapid Growth
 
Draganfly (Nasdaq: DPRO) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.
 
Watch Now
 
 
 
 
Bragg Gaming: Well Positioned for Profitable Future Growth
 
Bragg Gaming Group (NASDAQ: BRAG) is a growing global gaming technology and content group and owner of leading B2B companies in the iGaming industry. Since its inception in 2018, Bragg has grown to include operations across Europe, North America and Latin America and is expanding into an international force within the global online gaming market.
 
Watch Now
 
 
 
 
Elys: World-Class B2B-Focused Betting Platform
 
Elys Game Technology (Nasdaq: ELYS) is a fully integrated, turnkey end to end international gaming technology company providing an innovative, world class Betting and i-Casino platform for land based and digital gaming operators. With over 20 years of experience in regulated sports betting and i-gaming operating, the company utilizes two distribution channels: retail land-based or on-site physical venues, and online through PC, tablet and mobile distribution, either directly to licensed operators or through value-added re- sellers or systems integrators in the leisure betting industry.
 
Watch Now
 
 
 
 
Tiziana Life Sciences (NASDAQ: TLSA) Provides Pipeline Updates in Exclusive Investor Webinar
 
Tiziana Life Sciences is a dual listed (NASDAQ: TLSA, UK LSE: TILS) biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology, inflammation and infectious diseases. In addition to Milciclib, the Company will be shortly initiating Phase 2 studies with orally administered Foralumab for Crohn's Disease and nasally administered Foralumab for progressive multiple sclerosis.
 
Watch Now
 
 
 
 
Annovis Bio: Positive Phase 2 Data Sets Stage for Phase 3 Trials
 
Annovis Bio (NYSE American: ANVS) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS). Annovis is believed to be the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and improves the information highway of the nerve cell, known as axonal transport.
 
Watch Now
 
 
 
 
Interview with Magellan Gold: Center Star Gold Mine Project and a Hedge Against Rising Inflation
 
Magellan Gold Corp. is focused on the exploration and development of precious metals in North America. Magellan’s near-term production strategy and the potential expansion of its resource base and project portfolio are expected to drive strong shareholder value improvement moving forward.
 
Watch Now
 
 
 
 
CEO interview with EVmo: Leading Rental Car Provider for gig economy drivers
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Restarted Dividend Payments in Q2 2021
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns.
 
Watch Now
 
 
 
 
Virios Therapeutics: Interview with CEO
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
CEO interview with Esports Entertainment: Projecting $100M+ Revenue Over Next 12 Months
 
Esports Entertainment Group is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Late-Stage Development of First-in-Class Anti-Infectives
 
Aridis Pharmaceuticals (Nasdaq: ARDS) is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. The company’s lead drug candidate for acute pneumonia met the primary endpoint for its phase 2 clinical trial and the Company is now enrolling in a global phase 3 study.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the Recruiting Industry for the Digital Economy
 
Recruiter.com (Nasdaq: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
A recent study found that while certain mutual funds and ETFs delivered a 9.4% average annual return for the past decade, the average investor in these funds got only 7.7% due to poorly timed trading activity.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.